Warby Parker (WRBY) stock
Members see every stock ranked and every check behind each score, live.
Why it's down
Down 54% from its 5-year high in Nov 2021. The S&P 500 rose 63% over the same stretch.
Down more than its industry: the 59 other stocks in it fell a median 26% over the same stretch.
What's next
Expected to report Thu Nov 5, before the open
After its last 4 reports it closed +5.6% on average, higher 2 of 4 times.
What would move WRBY's score: 5 things, for members
Here is what members see.
Every stock gets a card like this one, and a page with its price in real time, every line of its score, the chart, and its filings.
WRBY has 6 of 14 checks firing
One per group is shown here.
How WRBY ranks in Medical Devices
WRBY is #14 of 75 by Quality Score. The top three are shown with their scores, and the rest by name.
DCTH8/1419
BLFS7/1419
HTFL9/1417
CBLLOpen for its score
WSTOpen for its score
WRBY6/1412
When does WRBY report, and what happens after?
Expected to report Thu Nov 5, before the open (in 36 days). Not yet confirmed by the company.
| Reported | When | Gap | Reaction | 5 sessions |
|---|---|---|---|---|
| Aug 6, 2026Before open | Before open | -14.3% | -7.9% | -13.5% |
| May 7, 2026Before open | Before open | +12.5% | +23.5% | +29.3% |
| Feb 26, 2026Before open | Before open | +1.1% | +17.8% | +25.7% |
| Nov 6, 2025Before open | Before open | -12.8% | -11.1% | -8.2% |
Who is trading WRBY
Insiders
One insider sold $265K across 1 filing in the last 6 months. No open-market buys on record. The newest:
Congress and the White House
2 trades disclosed in the last six months. The newest:
About Warby Parker
Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The Company provides holistic vision care by offering eyewear, contacts, and eye care directly to consumers through its integrated, omnichannel platform. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.
Every line of the score, on every stock.
- Real-time prices, no delay
- Every line of WRBY's score, with the points and the reason
- All 14 checks on WRBY and on all 2,953 stocks
- Every stock ranked, with the chart
- Every filing, and optional alerts on WRBY
Straight answers.
Are the prices delayed?
Only on the public pages, which run at least 15 minutes behind. Members, trial included, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Where does the data come from?
Daily bars, quotes, reference data, headlines, and short interest come from Massive, formerly Polygon, a licensed market data vendor. The age of the quotes is shown at the top of every page. Insider trades, notable holders and profits come straight from the SEC. That means Form 4 filings, 13F filings and XBRL financial data on EDGAR. Government filings come from the public STOCK Act and Office of Government Ethics disclosures. The market-wide headlines on the market line also come from the public headline feeds CNBC, MarketWatch and Yahoo Finance publish, shown as the headline, the source and a link to the article. Splits, dividends, and the financial statements on each ticker page come from the vendor's reference data. The 8-K filings on EDGAR are read for the items that move a price. Five years of history is loaded for every stock. So the 200-day and 52-week traits rest on real history. Options flow is not part of the product.
What does it cost?
Nothing for the first 8 days. After that, one plan with everything in it, only if you choose to subscribe: $29 a month, $69 for three months, or $249 a year. Payments go through Stripe, so Breakaway never sees your card.
Is this investment advice?
No. It is a screening tool that scores stocks on the chart, the company's own results, and the news and filings. It does not know your situation and it is not a recommendation to buy or sell anything. Please do your own research.